Cargando…
Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2)
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649459/ http://dx.doi.org/10.1186/2051-1426-3-S2-P225 |
| _version_ | 1782401362618744832 |
|---|---|
| author | Clark, Joseph I Morse, Michael A Wong, Michael KK McDermott, David F Kaufman, Howard L Daniels, Gregory A Perritt, Jessica C Hua, Hong Aung, Sandra |
| author_facet | Clark, Joseph I Morse, Michael A Wong, Michael KK McDermott, David F Kaufman, Howard L Daniels, Gregory A Perritt, Jessica C Hua, Hong Aung, Sandra |
| author_sort | Clark, Joseph I |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649459 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46494592015-11-24 Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2) Clark, Joseph I Morse, Michael A Wong, Michael KK McDermott, David F Kaufman, Howard L Daniels, Gregory A Perritt, Jessica C Hua, Hong Aung, Sandra J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649459/ http://dx.doi.org/10.1186/2051-1426-3-S2-P225 Text en Copyright © 2015 Clark et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Clark, Joseph I Morse, Michael A Wong, Michael KK McDermott, David F Kaufman, Howard L Daniels, Gregory A Perritt, Jessica C Hua, Hong Aung, Sandra Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2) |
| title | Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2) |
| title_full | Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2) |
| title_fullStr | Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2) |
| title_full_unstemmed | Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2) |
| title_short | Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2) |
| title_sort | durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (hd il-2) |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649459/ http://dx.doi.org/10.1186/2051-1426-3-S2-P225 |
| work_keys_str_mv | AT clarkjosephi durabilityofresponsesinpatientswithmetastaticrenalcellcarcinomatreatedwithhighdoseinterleukin2hdil2 AT morsemichaela durabilityofresponsesinpatientswithmetastaticrenalcellcarcinomatreatedwithhighdoseinterleukin2hdil2 AT wongmichaelkk durabilityofresponsesinpatientswithmetastaticrenalcellcarcinomatreatedwithhighdoseinterleukin2hdil2 AT mcdermottdavidf durabilityofresponsesinpatientswithmetastaticrenalcellcarcinomatreatedwithhighdoseinterleukin2hdil2 AT kaufmanhowardl durabilityofresponsesinpatientswithmetastaticrenalcellcarcinomatreatedwithhighdoseinterleukin2hdil2 AT danielsgregorya durabilityofresponsesinpatientswithmetastaticrenalcellcarcinomatreatedwithhighdoseinterleukin2hdil2 AT perrittjessicac durabilityofresponsesinpatientswithmetastaticrenalcellcarcinomatreatedwithhighdoseinterleukin2hdil2 AT huahong durabilityofresponsesinpatientswithmetastaticrenalcellcarcinomatreatedwithhighdoseinterleukin2hdil2 AT aungsandra durabilityofresponsesinpatientswithmetastaticrenalcellcarcinomatreatedwithhighdoseinterleukin2hdil2 |